Literature DB >> 21547485

Predictors of resistant hypertension in an unselected sample of an adult male population in Italy.

Antonio Barbato1, Ferruccio Galletti, Roberto Iacone, Francesco P Cappuccio, Giovanni Rossi, Renato Ippolito, Antonella Venezia, Eduardo Farinaro, Pasquale Strazzullo.   

Abstract

Prevalence, incidence and predictors of resistant hypertension (RH), (defined as blood pressure persistently above goal in spite of the concurrent use of three antihypertensive agents of different classes) in the general population remain largely unknown. A complete database including anthropometric and biochemical data was collected in 1994-1995 (baseline examination) in 1,019 participants (mean age 51.8, range: 25-79 years) and again in 2002-2004 in 794 male participants of the Olivetti Heart Study (OHS) in southern Italy. The incidence of RH over the average follow-up time of 7.9 years was 4.8% (38/794) in the whole study population and 10.1% (31/307) among hypertensive participants. Basal blood pressure (systolic, diastolic or pulse pressure), cholesterol and urinary albumin/creatinine ratio (ACR) significantly predicted the risk of developing RH using a logistic regression model that also included age as covariates. If in the same model we added basal pharmacological treatment, the fractional excretion of sodium (FENa) also became a statistically significant predictor, and this last model explained nearly 25% of the risk of developing RH. In this unselected sample of an adult male population, ACR (an early marker of organ damage), an elevated FENa (a proxy for dietary sodium intake), cholesterol and a higher basal blood pressure level were independent predictors of RH.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21547485     DOI: 10.1007/s11739-011-0554-2

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  38 in total

1.  Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation.

Authors:  W F Keane; G Eknoyan
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

2.  Salt and cardiovascular disease.

Authors:  Francesco P Cappuccio
Journal:  BMJ       Date:  2007-04-28

3.  Management of hypertension. Clinical and hemodynamic studies with special reference to patients refractory to treatment.

Authors:  O Andersson
Journal:  Acta Med Scand Suppl       Date:  1977

Review 4.  Resistant hypertension.

Authors:  Norman M Kaplan
Journal:  J Hypertens       Date:  2005-08       Impact factor: 4.844

5.  Prevalence of drug resistant hypertension.

Authors:  M H Alderman; N Budner; H Cohen; B Lamport; W L Ooi
Journal:  Hypertension       Date:  1988-03       Impact factor: 10.190

6.  Aldosterone induces a vascular inflammatory phenotype in the rat heart.

Authors:  Ricardo Rocha; Amy E Rudolph; Gregory E Frierdich; Denise A Nachowiak; Beverly K Kekec; Eric A G Blomme; Ellen G McMahon; John A Delyani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11       Impact factor: 4.733

7.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

8.  Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria.

Authors:  M R Weir; D R Dengel; M T Behrens; A P Goldberg
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

Review 9.  A comprehensive review on salt and health and current experience of worldwide salt reduction programmes.

Authors:  F J He; G A MacGregor
Journal:  J Hum Hypertens       Date:  2008-12-25       Impact factor: 3.012

10.  Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

Authors:  E Bonora; S Kiechl; J Willeit; F Oberhollenzer; G Egger; G Targher; M Alberiche; R C Bonadonna; M Muggeo
Journal:  Diabetes       Date:  1998-10       Impact factor: 9.461

View more
  4 in total

1.  Validation of daily urinary creatinine excretion measurement by muscle-creatinine equivalence.

Authors:  Roberto Iacone; Lanfranco D'Elia; Bruna Guida; Antonio Barbato; Clelia Scanzano; Pasquale Strazzullo
Journal:  J Clin Lab Anal       Date:  2018-02-09       Impact factor: 2.352

2.  Renal denervation for resistant hypertension: yes.

Authors:  Enrico Boschetti; Yahya Alrashdi; Giuseppe Schillaci
Journal:  Intern Emerg Med       Date:  2016-03-12       Impact factor: 3.397

3.  Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: results from the MINISAL-SIIA study program.

Authors:  F Galletti; A Barbato
Journal:  J Hum Hypertens       Date:  2016-03-03       Impact factor: 3.012

4.  Renal denervation for resistant hypertension: no.

Authors:  Stefano Taddei; Elisa Dal Canto; Rosa Maria Bruno
Journal:  Intern Emerg Med       Date:  2016-03-21       Impact factor: 3.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.